Tags

Type your tag names separated by a space and hit enter

Community-associated meticillin-resistant Staphylococcus aureus.
Lancet. 2010 May 01; 375(9725):1557-68.Lct

Abstract

Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in individuals with predisposing risk factors, such as surgery or presence of an indwelling medical device. By contrast, many community-associated MRSA (CA-MRSA) infections arise in otherwise healthy individuals who do not have such risk factors. Additionally, CA-MRSA infections are epidemic in some countries. These features suggest that CA-MRSA strains are more virulent and transmissible than are traditional hospital-associated MRSA strains. The restricted treatment options for CA-MRSA infections compound the effect of enhanced virulence and transmission. Although progress has been made towards understanding emergence of CA-MRSA, virulence, and treatment of infections, our knowledge remains incomplete. Here we review the most up-to-date knowledge and provide a perspective for the future prophylaxis or new treatments for CA-MRSA infections.

Authors+Show Affiliations

Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA. fdeleo@niaid.nih.govNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Review

Language

eng

PubMed ID

20206987

Citation

DeLeo, Frank R., et al. "Community-associated Meticillin-resistant Staphylococcus Aureus." Lancet (London, England), vol. 375, no. 9725, 2010, pp. 1557-68.
DeLeo FR, Otto M, Kreiswirth BN, et al. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010;375(9725):1557-68.
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010). Community-associated meticillin-resistant Staphylococcus aureus. Lancet (London, England), 375(9725), 1557-68. https://doi.org/10.1016/S0140-6736(09)61999-1
DeLeo FR, et al. Community-associated Meticillin-resistant Staphylococcus Aureus. Lancet. 2010 May 1;375(9725):1557-68. PubMed PMID: 20206987.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Community-associated meticillin-resistant Staphylococcus aureus. AU - DeLeo,Frank R, AU - Otto,Michael, AU - Kreiswirth,Barry N, AU - Chambers,Henry F, Y1 - 2010/03/05/ PY - 2010/3/9/entrez PY - 2010/3/9/pubmed PY - 2010/6/11/medline SP - 1557 EP - 68 JF - Lancet (London, England) JO - Lancet VL - 375 IS - 9725 N2 - Meticillin-resistant Staphylococcus aureus (MRSA) is endemic in hospitals worldwide, and causes substantial morbidity and mortality. Health-care-associated MRSA infections arise in individuals with predisposing risk factors, such as surgery or presence of an indwelling medical device. By contrast, many community-associated MRSA (CA-MRSA) infections arise in otherwise healthy individuals who do not have such risk factors. Additionally, CA-MRSA infections are epidemic in some countries. These features suggest that CA-MRSA strains are more virulent and transmissible than are traditional hospital-associated MRSA strains. The restricted treatment options for CA-MRSA infections compound the effect of enhanced virulence and transmission. Although progress has been made towards understanding emergence of CA-MRSA, virulence, and treatment of infections, our knowledge remains incomplete. Here we review the most up-to-date knowledge and provide a perspective for the future prophylaxis or new treatments for CA-MRSA infections. SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/20206987/Community_associated_meticillin_resistant_Staphylococcus_aureus_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(09)61999-1 DB - PRIME DP - Unbound Medicine ER -